Add to ORKGare Rare): methods to facilitate the analysis of iants from massively publication identifying XRCC2 as a new breast cancer risk gene and have been made publically available as a suite Pope et al. BMC Bioinformatics 2013, 14:6
cancer risk prediction and individualised screening based on common genetic variation and breast den...
© 2007 Huijts et al, licensee BioMed Central Ltd. This is an open access article distributed under t...
Background: Systematic approaches for identifying proteins involved in different types of cancer are...
BACKGROUND: Characterising genetic diversity through the analysis of massively parallel sequencing (...
ar nt is one of the main challenges in functional genomics and In particular, DE analysis is a widel...
Identifying cancer mutation targets across thousands of samples: MuteProc, a high throughput mutatio...
Introduction: Breast cancer is a complex heterogeneous disease for which a substantial resource of t...
Interrogating differences in expression of targeted gene sets to predict breast cancer outcom
methodology for quantification of COL11A1 mRNA variants and evaluation in breast cancer tissue speci...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
Background: CHEK2*1100delC is a moderate-risk breast cancer susceptibility allele with a high preval...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
tool to improve the clinical utility of computational CNV prediction from exome sequencing dat
Item does not contain fulltextAn exome-sequencing study of families with multiple breast-cancer-affe...
ian on f C an en nical obstacle to GWAS on rare variants is the calling predicted additional loci to...
cancer risk prediction and individualised screening based on common genetic variation and breast den...
© 2007 Huijts et al, licensee BioMed Central Ltd. This is an open access article distributed under t...
Background: Systematic approaches for identifying proteins involved in different types of cancer are...
BACKGROUND: Characterising genetic diversity through the analysis of massively parallel sequencing (...
ar nt is one of the main challenges in functional genomics and In particular, DE analysis is a widel...
Identifying cancer mutation targets across thousands of samples: MuteProc, a high throughput mutatio...
Introduction: Breast cancer is a complex heterogeneous disease for which a substantial resource of t...
Interrogating differences in expression of targeted gene sets to predict breast cancer outcom
methodology for quantification of COL11A1 mRNA variants and evaluation in breast cancer tissue speci...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
Background: CHEK2*1100delC is a moderate-risk breast cancer susceptibility allele with a high preval...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
tool to improve the clinical utility of computational CNV prediction from exome sequencing dat
Item does not contain fulltextAn exome-sequencing study of families with multiple breast-cancer-affe...
ian on f C an en nical obstacle to GWAS on rare variants is the calling predicted additional loci to...
cancer risk prediction and individualised screening based on common genetic variation and breast den...
© 2007 Huijts et al, licensee BioMed Central Ltd. This is an open access article distributed under t...
Background: Systematic approaches for identifying proteins involved in different types of cancer are...